4.7 Review

The pathogenesis of organ fibrosis: Focus on necroptosis

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 180, 期 22, 页码 2862-2879

出版社

WILEY
DOI: 10.1111/bph.15952

关键词

liver fibrosis; lung fibrosis; MLKL; necroptosis; RIPK1; 3; tissue fibrosis

向作者/读者索取更多资源

Fibrosis is a common response to chronic progressive diseases, characterized by excessive deposition of extracellular matrix. Different types of cell death are closely related to organ fibrosis, among which necroptosis is considered as a potential target to ameliorate fibrosis.
Fibrosis is a common process of tissue repair response to multiple injuries in all chronic progressive diseases, which features with excessive deposition of extracellular matrix. Fibrosis can occur in all organs and tends to be nonreversible with the progress of the disease. Different cells types in different organs are involved in the occurrence and development of fibrosis, that is, hepatic stellate cells, pancreatic stellate cells, fibroblasts and myofibroblasts. Various types of programmed cell death, including apoptosis, autophagy, ferroptosis and necroptosis, are closely related to organ fibrosis. Among these programmed cell death types, necroptosis, an emerging regulated cell death type, is regarded as a huge potential target to ameliorate organ fibrosis. In this review, we summarize the role of necroptosis signalling in organ fibrosis and collate the small molecule compounds targeting necroptosis. In addition, we discuss the potential challenges, opportunities and open questions in using necroptosis signalling as a potential target for antifibrotic therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据